Difference between revisions of "Nephrotic syndrome"

Jump to navigation Jump to search
1,059 bytes added ,  19:13, 11 November 2011
→‎See also: +C1q nephropathy
(→‎See also: +C1q nephropathy)
Line 166: Line 166:
===EM===  
===EM===  
*Diffuse subepithelial deposits - spike forming.
*Diffuse subepithelial deposits - spike forming.
==C1q nephropathy==
===General===
*Nephrotic syndrome.
*Controversial entity - may be a variant of FSGS.<ref name=pmid12969141>{{Cite journal  | last1 = Markowitz | first1 = GS. | last2 = Schwimmer | first2 = JA. | last3 = Stokes | first3 = MB. | last4 = Nasr | first4 = S. | last5 = Seigle | first5 = RL. | last6 = Valeri | first6 = AM. | last7 = D'Agati | first7 = VD. | title = C1q nephropathy: a variant of focal segmental glomerulosclerosis. | journal = Kidney Int | volume = 64 | issue = 4 | pages = 1232-40 | month = Oct | year = 2003 | doi = 10.1046/j.1523-1755.2003.00218.x | PMID = 12969141 }}</ref>
*Steroid resistant - like FSGS.<ref name=pmid3875286>{{Cite journal  | last1 = Jennette | first1 = JC. | last2 = Hipp | first2 = CG. | title = C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. | journal = Am J Kidney Dis | volume = 6 | issue = 2 | pages = 103-10 | month = Aug | year = 1985 | doi =  | PMID = 3875286 }}</ref>
===Microscopic===
Features:
*[[Focal segmental glomerulosclerosis]].
===IF===
*C1q +ve.


=See also=
=See also=
48,707

edits

Navigation menu